Bookmark
Forward
Explore Literature Results
QuickView for C-FMS;jsessionid=C3573561C82F2633AC01D5B18CDE5741;jsessionid=EEE5F445257F5218500D2433C50F11FC;jsessionid=57C7CED8C80CF0CE2E53C141A4AA1996;jsessionid=BA7615F9B21A7F2A54DD9B1088F268C3;jsessionid=C68E6BF8ABE52705CF7A84331640C1C4 (gene)
Most Correlated Tissues
Task java.util.concurrent.FutureTask@384d3627 rejected from java.util.concurrent.ThreadPoolExecutor@527b86ce[Running, pool size = 100, active threads = 100, queued tasks = 0, completed tasks = 30437492]
Explore Body Atlas Results
Most Correlated Studies
There were no matches for C-FMS;jsessionid=C3573561C82F2633AC01D5B18CDE5741;jsessionid=EEE5F445257F5218500D2433C50F11FC;jsessionid=57C7CED8C80CF0CE2E53C141A4AA1996;jsessionid=BA7615F9B21A7F2A54DD9B1088F268C3;jsessionid=C68E6BF8ABE52705CF7A84331640C1C4
Explore Curated Studies Results
Most Relevant Literature
- CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment.
- A highly selective purine-based inhibitor of CSF1R potently inhibits osteoclast differentiation.
- Engineering an inhibitor-resistant human CSF1R variant for microglia replacement.
- A kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy has a dominant inhibito…
- CSF1R inhibitors induce a sex-specific resilient microglial phenotype and functional rescue in a tau…
Most Relevant Clinical Trials
Task java.util.concurrent.FutureTask@687dd6e6 rejected from java.util.concurrent.ThreadPoolExecutor@527b86ce[Running, pool size = 100, active threads = 99, queued tasks = 0, completed tasks = 30437492]
Explore Clinical Trials Results
